Bayer-Monsanto Merger Plan Draws US Senate Scrutiny

The U.S. Senate is taking a closer look Tuesday at a proposed $66 billion merger of American seed and weed-killer company Monsanto and German medicine and farm chemical maker Bayer. The deal would combine two of the six U.S. and European companies that dominate the agrochemical market and would create a global agricultural and chemical giant with a broad array of products. The Senate Judiciary Committee chairman, Republican Senator Charles Grassley of Iowa, has said he's concerned...

© La Voix de l'Amérique - mardi 20 septembre 2016